Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 56% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 1 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
7 authors at 3 institutions in 1 country.
Tatiana J CarneiroDepartment of Chemistry, CICECO-Aveiro Institute of Materials, University of Aveiro, 3810-193 Aveiro, Portugal.ORCID 0000-0003-4841-7860
Martin VojtekLAQV/REQUIMTE-Associated Laboratory for Green Chemistry of the Network of Chemistry and Technology, Laboratory of Pharmacology, Department of Drug Sciences, Faculty of Pharmacy, University of Porto, 4150-755 Porto, Portugal.ORCID 0000-0002-9257-7020
Salomé Gonçalves-MonteiroLAQV/REQUIMTE-Associated Laboratory for Green Chemistry of the Network of Chemistry and Technology, Laboratory of Pharmacology, Department of Drug Sciences, Faculty of Pharmacy, University of Porto, 4150-755 Porto, Portugal.
Ana L M Batista de CarvalhoMolecular Physical-Chemistry R&D Unit, Department of Chemistry, University of Coimbra, 3004-535 Coimbra, Portugal.ORCID 0000-0003-1280-3321
Maria Paula M MarquesMolecular Physical-Chemistry R&D Unit, Department of Chemistry, University of Coimbra, 3004-535 Coimbra, Portugal.ORCID 0000-0002-8391-0055
Carmen DinizLAQV/REQUIMTE-Associated Laboratory for Green Chemistry of the Network of Chemistry and Technology, Laboratory of Pharmacology, Department of Drug Sciences, Faculty of Pharmacy, University of Porto, 4150-755 Porto, Portugal.ORCID 0000-0003-4668-9360
Ana M GilDepartment of Chemistry, CICECO-Aveiro Institute of Materials, University of Aveiro, 3810-193 Aveiro, Portugal.ORCID 0000-0003-3766-4364
Universidade do Porto · PTUniversity of Aveiro · PTUniversity of Coimbra · PT
Funding
Fundação para a Ciência e Tecnologia LAQV/REQUIMTE FCT UIDB/50006/2020 (POCentro, Portugal 2020 and European Community through the FEDER and by the Portuguese Foundation for Science and Technology)Fundação para a Ciência e Tecnologia Portuguese National NMR Network (PTNMR), Infrastructure Project No. 022161Fundação para a Ciência e Tecnologia UIDB/00070/2020, POCI-01-0145-FEDER-0016786, SFRH/BD/145920/2019, PD/BD/135460/2017Fundação para a Ciência e Tecnologia (UIDB/50011/2020, UIDP/50011/2020 & LA/P/0006/2020), FCT/MEC (PIDDAC)
6 · The paper itself
Abstract
Cisplatin (cDDP)-based chemotherapy is often limited by severe deleterious effects (nephrotoxicity, hepatotoxicity and neurotoxicity). The polynuclear palladium(II) compound Pd
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.